Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The TRANSCEND-T2D-1 trial adds a second pressure point: 16.8% body weight reduction in patients with type 2 diabetes, a population that consistently underperforms on weight-loss endpoints with existing agents
If weight loss or glycemic control is the goal today, tirzepatide is the option with an approval, a known supply chain, and an established safety database
Introduction to Semaglutide and Its Role in Weight Management Semaglutide has made a big impact in weight management
A slight weight increase of 1 to 3 pounds between weeks is also normal, especially around dose increases, during the first few days of a new exercise routine, or during menstrual cycles
A 2025 study published in JMIR Formative Research found that active subscribers on Second Natures GLP-1-supported programme lost an average of 19.1% of their body weight at 12 months, with 77.7% achieving at least 10% weight loss
US$ 25.42
US$ 28.15
US$ 28.14
US$ 28.63
US$ 25.06
US$ 24.61
US$ 22.18
US$ 28.38
US$ 25.43
US$ 21.27
US$ 23.69
US$ 21.82
US$ 20.25
